Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT03989349. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of the study was to assess the efficacy and safety of nemolizumab after a 16-week treatment period in adult and adolescent subjects with moderate-to-severe atopic dermatitis (AD) not adequately controlled with topical treatments.
Study identification
- NCT ID
- NCT03989349
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 787 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2019 (Actual)
- Primary completion
- Feb 23, 2022 (Actual)
- Completion
- Sep 26, 2022 (Actual)
- Last update posted
- Aug 14, 2024
2019 – 2022
United States locations
- U.S. sites
- 47
- U.S. states
- 21
- U.S. cities
- 41
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Galderma Investigational Site 8749 | Birmingham | Alabama | 35244 | — |
| Galderma Investigational Site 8893 | Birmingham | Alabama | 35244 | — |
| Galderma Investigational Site 8866 | Guntersville | Alabama | 35976 | — |
| Galderma Investigational Site 8808 | Scottsdale | Arizona | 85255 | — |
| Galderma Investigational Site 8906 | Bell Gardens | California | 90201 | — |
| Galderma Investigational Site 8905 | Canoga Park | California | 91304 | — |
| Galderma Investigational Site 8577 | Encinitas | California | 92024 | — |
| Galderma Investigational Site 8673 | Garden Grove | California | 92840 | — |
| Galderma Investigational Site 8683 | Los Angeles | California | 90033 | — |
| Galderma Investigational Site 8907 | Newport Beach | California | 92660 | — |
| Galderma Investigational Site 8799 | Ontario | California | 91762 | — |
| Galderma Investigational Site 8745 | Pasadena | California | 91105 | — |
| Galderma Investigational Site 8658 | San Diego | California | 92123 | — |
| Galderma Investigational Site 8536 | Santa Ana | California | 92705 | — |
| Galderma Investigational Site 8820 | Westminster | California | 92683 | — |
| Galderma Investigational Site 8637 | Farmington | Connecticut | 06030 | — |
| Galderma Investigational Site 8875 | Delray Beach | Florida | 33484 | — |
| Galderma Investigational Site 8391 | Hialeah | Florida | 33013 | — |
| Galderma Investigational Site 8727 | Hialeah | Florida | 33016 | — |
| Galderma Investigational Site 8523 | Largo | Florida | 33770 | — |
| Galderma Investigational Site 8719 | Miami | Florida | 33125 | — |
| Galderma Investigational Site 8656 | Miami | Florida | 33137 | — |
| Galderma Investigational Site 8704 | Miami | Florida | 33155 | — |
| Galderma Investigational Site 8706 | Miami | Florida | 33175 | — |
| Galderma Investigational Site 8203 | Tampa | Florida | 33607 | — |
| Galderma Investigational Site 8839 | Tampa | Florida | 33615 | — |
| Galderma Investigational Site 8729 | Rolling Meadows | Illinois | 60008 | — |
| Galderma Investigational Site 8724 | New Albany | Indiana | 47150 | — |
| Galderma Investigational Site 8554 | Detroit | Michigan | 48202 | — |
| Galderma Investigational Site 8825 | Las Vegas | Nevada | 89106 | — |
| Galderma Investigational Site 8506 | Hackensack | New Jersey | 07601 | — |
| Galderma Investigational Site 8741 | Buffalo | New York | 14221 | — |
| Galderma Investigational Site 8723 | Cortland | New York | 13045 | — |
| Galderma Investigational Site 8733 | New York | New York | 10022 | — |
| Galderma Investigational Site 8823 | Greensboro | North Carolina | 27408 | — |
| Galderma Investigational Site 8030 | Raleigh | North Carolina | 27612 | — |
| Galderma Investigational Site 8747 | Cincinnati | Ohio | 45219 | — |
| Galderma Investigational Site 8212 | Portland | Oregon | 97210 | — |
| Galderma Investigational Site 8721 | Pittsburgh | Pennsylvania | 15213 | — |
| Galderma Investigational Site 8713 | North Charleston | South Carolina | 29420 | — |
| Galderma Investigational Site 8705 | Chattanooga | Tennessee | 37421 | — |
| Galderma Investigational Site 8807 | Houston | Texas | 77029 | — |
| Galderma Investigational Site 8618 | Waco | Texas | 76710 | — |
| Galderma Investigational Site 8003 | Webster | Texas | 77598 | — |
| Galderma Investigational Site 8672 | Salt Lake City | Utah | 84117 | — |
| Galderma Investigational Site 8896 | Richmond | Virginia | 23219 | — |
| Galderma Investigational Site 8434 | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 91 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03989349, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 14, 2024 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03989349 live on ClinicalTrials.gov.